CHPA applauds New Hampshire for becoming the 35th state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx), a system used by retailers across the country to help prevent the illegal sale of pseudoephedrine.
CHPA applauds the U.S. House Ways and Means Health Subcommittee for today’s hearing, examining the benefits of consumer access to tax-preferred savings accounts, HSAs and FSAs.
The CHPA Educational Foundation today released findings from a study examining the common attitudes and behaviors of parents when administering pediatric over-the-counter (OTC) liquid medicines to young children.
Colorado Governor John Hickenlooper signed into law HB 1307, legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.
We are encouraged by the ongoing, bipartisan momentum behind this reform and look forward to seeing the legislation move forward in the House as well as the Senate.
Overwhelming scientific evidence shows that excess sun exposure without sunscreen increases the risk of developing skin cancer. Banning key ingredients in effective sunscreens will unnecessarily reduce the selection of safe and effective sunscreen products available.
CHPA applauds FDA for issuing a recent order in support of the full and complete switch from prescription to nonprescription status for the laxative active ingredient polyethylene glycol (PEG) 3350.
Today, the United States Senate Health, Education, Labor and Pensions (HELP) Committee approved S. 2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a 22-1 vote.
CHPA thanks Governor Walker for signing this important bill into law as well as Senator Stroebel and Representative Kremer for their leadership and commitment to passing legislation aimed at addressing the issue of teen OTC cough medicine abuse
CHPA released the following statement today by President and CEO, Scott Melville, applauding the introduction of The Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Best practices for consumers looking to make evidence-informed decisions when shopping for dietary supplements, including avoiding red-flag ingredients such as SARMs.
We applaud FDA for focusing their enforcement efforts on homeopathic drug products that do not meet manufacturing standards, contain harmful ingredients, or are OTC products with prescription indications.
